| AMD |
Report |
Total Revenue (Q2'26) |
BEAT |
pred ~$11.44B vs. cons $11.31B |
MEDIUM |
| AMD |
Report |
Non-GAAP EPS (Q2'26) |
BEAT |
pred ~$1.65 vs. cons $1.62 |
MEDIUM |
| AMD |
Report |
Data Center segment revenue (Q2'26) |
BEAT |
pred ~$6.60B vs. cons $6.45B |
MEDIUM |
| AMD |
Guide |
Q3'26 Revenue guide |
BETTER |
guide ~$12.30B vs. cons $12.00B (Q3 2026) |
MEDIUM |
| AMD |
Guide |
Q3'26 Non-GAAP gross margin guide |
LOWER |
guide ~56.0% vs. cons 56.5% (Q3 2026) |
MEDIUM |
| AMD |
Guide |
Data Center AI/Helios ramp & long-term CAGR commentary |
BETTER |
guide ~'exceed 80% CAGR' vs. cons ~80% CAGR (FY2026-2027 outlook) |
LOW |
| AMD |
Guide |
H2 Gaming revenue decline commentary |
UNCHANGED |
guide ~-20%+ H2 vs H1 vs. cons -20% H2 vs H1 (H2 2026) |
MEDIUM |
| AMD |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.0% |
— |
MEDIUM |
| AMD |
Return |
5-day cumulative residual |
+1.2% (FADE) |
A likely beat-and-raise on revenue/EPS and a strong Q3 revenue guide should drive an initial positive idiosyncratic pop, but with ~12% of implied move already priced in and sell-side estimates having risen sharply pre-print, the bar for sustained upside is high. Margin guidance likely softens slightly (MI450/Helios ramp costs, H2 gaming decline from memory inflation) even as top-line accelerates, prompting some analysts to trim near-term EPS/margin estimates even after a top-line beat (implicit out-period cut). Combined with lingering 'circular financing' scrutiny around the Anthropic/Core Scientific deal structures, the initial pop should partially fade over the following days rather than fully follow through, though strong underlying AI demand signals should prevent a full reversal (stabilizing above pre-print levels but below the day-1 spike). |
MEDIUM |